Navigation Links
Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development

PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ -- Premier Research Group announces the appointment of Susan C. Stansfield, PhD to the position of Executive Vice President, Clinical Development. In this position, Dr. Stansfield will have global responsibility for leading and developing the company's clinical trial management services provided to the biopharmaceutical industry.

"Sue's deep industry knowledge and proven leadership skills will be pivotal in enhancing the value our clinical development organization provides to our customers," commented Dr. Ludo Reynders, Chief Executive Officer. "As demand for our services continues to grow, Sue will focus on ensuring that scientific and operational excellence remains at the heart of our organization. Sue's exceptional skills and experience in the areas of program and project management will be invaluable in providing superior and appropriate services to our customers in today's rapidly changing drug development world."

Dr. Stansfield comes to Premier Research with an exceptional track record of more than 25 years in the pharmaceutical and contract research industries. Dr. Stansfield worked at three of the leading clinical service organizations (PRA, PPD and Quintiles) taking increasingly responsible leadership roles in project management and clinical operations. This included responsibility for 2,000 staff located in 50 countries. Dr. Stansfield holds a Doctorate in Neuropharmacology from Reading University in the UK and a Bachelor in Science from Nottingham University.

About Premier Research
Premier Research is a professional services company providing clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide.  The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it provides a strong strategic sourcing group that supports customers in their resource planning and management.

The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.

For more information please visit,

SOURCE Premier Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Micronutrient Launches Supplement for Hearing Health
2. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
3. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
4. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Expands its Medical Device Operations to the United States
7. Premier Research Announces Milestone Investigational New Drug Application
8. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
9. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
10. Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
11. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
Post Your Comments:
(Date:11/27/2015)... 2015 Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... Une nouvelle approche consistant à combiner l,immunothérapie au ...    Clinical Cancer Research . ...
(Date:11/27/2015)... , November 27, 2015 ... set to go online. The potential to save costs, ... vast and far from fully exploited as yet. Here, ... health records, either via mobile tablet or directly at ... --> ) -->      ...
(Date:11/27/2015)... Niederlande, November 27, 2015 ... bei fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   Clinical Cancer Research ... Clinical Cancer Research vom 6. November ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special ... 10% off of their purchase of lice treatment product. In addition, customers will receive ... a company spokesperson. “Finding lice is a sure way to ruin the holidays, so ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community ... 30 (see Table 1-1 ). More than 3.7 billion people under the age ... type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices ... show that delves into an array of issues that are presently affecting Americans. Dedicated ... open dialogue, this show is changing the subjects consumers focus on, one episode at ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is ... Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College ... as only one of twelve colleges and universities in the state of California make ...
Breaking Medicine News(10 mins):